Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.

Poetsch N, Sturdza A, Aust S, Polterauer S, Grimm C, Schwameis R, Pötter R, Koelbl H, Reinthaller A, Seebacher V.

Strahlenther Onkol. 2019 May;195(5):430-440. doi: 10.1007/s00066-019-01430-z. Epub 2019 Feb 8.


Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.

Seebacher V, Sturdza A, Bergmeister B, Polterauer S, Grimm C, Reinthaller A, Hilal Z, Aust S.

Arch Gynecol Obstet. 2019 Apr;299(4):1055-1062. doi: 10.1007/s00404-018-4993-0. Epub 2018 Dec 10.


The prognostic role of metformin in patients with endometrial cancer: a retrospective study.

Seebacher V, Bergmeister B, Grimm C, Koelbl H, Reinthaller A, Polterauer S.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:291-6. doi: 10.1016/j.ejogrb.2016.06.013. Epub 2016 Jun 29.


The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer.

Seebacher V, Grimm C, Reinthaller A, Heinze G, Tempfer C, Hefler L, Polterauer S.

Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):101-6. doi: 10.1016/j.ejogrb.2013.07.044. Epub 2013 Aug 11.


The impact of plasma fibrinogen levels on patients with vulvar cancer.

Seebacher V, Polterauer S, Grimm C, Tempfer C, Hefler-Frischmuth K, Reinthaller A, Hefler L.

Eur J Obstet Gynecol Reprod Biol. 2012 Mar;161(1):88-91. doi: 10.1016/j.ejogrb.2011.11.030. Epub 2012 Feb 4.


The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.

Seebacher V, Polterauer S, Grimm C, Husslein H, Leipold H, Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L.

Br J Cancer. 2010 Mar 16;102(6):952-6. doi: 10.1038/sj.bjc.6605547. Epub 2010 Feb 16.

Supplemental Content

Loading ...
Support Center